View Discovery

Clinical Pipeline

Trials for Market Approval Download PPT

Pre-Clinical (GLP)


GlaxoSmithKline, TB Drug Accelerator
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF)
TB Alliance, University of Auckland
TB Alliance, Institute of Materia Medica
Microbiotix, Inc.

Phase 1


GlaxoSmithKline
iM4TB - Innovative Medicines for Tuberculosis, Bill & Melinda Gates Foundation
Institute of Materia Medica, CAMS & PUMC
Otsuka Pharmaceutical Development & Commercialization, Inc.
TB Alliance
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund

Phase 2


Nearmedic Plus LLC
Sequella, Inc
Médecins Sans Frontières
The Aurum Institute NPC, Calibr, The Scripps Research Institute
Sequella, Inc
NIAID, NIH, DHHS, Bill & Melinda Gates Foundation, EDCTP
CDC TBTC, NIAID, NIH, DHHS, Boston University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
Weill Medical College of Cornell University

Phase 3


University College, London, SPRINT TB (National University of Singapore)
Médecins Sans Frontières
Novartis
St. George's Hospital University of London